Bain Capital Investors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.69B | Hold |
|
|||||
|
2024
Q1 | $2.78B | Hold |
|
|||||
|
2023
Q4 | $2.78B | Buy |
|
|||||
|
2023
Q3 | $1.31B | Hold |
|
|||||
|
2023
Q2 | $1.91B | Sell |
|
|||||
|
2023
Q1 | $1.48B | Hold |
|
|||||
|
2022
Q4 | $1.91B | Hold |
|
|||||
|
2022
Q3 | $1.71B | Hold |
|
|||||
|
2022
Q2 | $1.6B | Hold |
|
|||||
|
2022
Q1 | $2.12B | Hold |
|
|||||
|
2021
Q4 | $1.97B | Hold |
|
|||||
|
2021
Q3 | $1.79B | Hold |
|
|||||
|
2021
Q2 | $1.55B | Hold |
|
|||||
|
2021
Q1 | $832M | Hold |
|
|||||
|
2020
Q4 | $1.01B | Buy |
|